Obiettivo
Venomous animals represent a major source of highly selective and efficient bioactive compounds that have already led to the development of several new drugs. The latest FDA approved example is Prialt, a peptide originating from the venom of a cone snail (Conus magus). CONCO is an innovative post-genomic project dedicated to the discovery and development of novel biopharmaceuticals generated by the broad biodiversity of cone snails.
The project aims at characterizing from the genomic up to potential therapeutic properties all the putative bioactive compounds that can be synthesised by a cone snail species. The genome and transcriptome of Conus consors will be exhaustively studied. Large amounts of venom will be fractionated and submitted to proteomic studies to generate a biochemically characterized 'natural library' of compounds. Large-scale synthesis of each identified candidate will be achieved to form a "synthetic library" of compounds.
Campo scientifico
Argomento(i)
Invito a presentare proposte
FP6-2005-LIFESCIHEALTH-6
Vedi altri progetti per questo bando
Meccanismo di finanziamento
IP - Integrated ProjectCoordinatore
PLAN-LES-OUATES - GENEVA
Svizzera
Mostra sulla mappa
Partecipanti (19)
PLAN-LES-OUATES
Mostra sulla mappa
FRANKFURT AM MAIN
Mostra sulla mappa
ROCKVILLE, MARYLAND
Mostra sulla mappa
MONTPELLIER
Mostra sulla mappa
BRATISLAVA
Mostra sulla mappa
PARIS
Mostra sulla mappa
ISSY-LES-MOULINEAUX
Mostra sulla mappa
1211 Geneva 4 GENEVA
Mostra sulla mappa